CT Cardiomegaly vs KardiaAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Innolitics
VS
by AliveCor

AI Verdict

While both tools leverage AI in cardiology, they address different diagnostic needs and utilize distinct data modalities. CT Cardiomegaly focuses on analyzing CT chest images for cardiomegaly detection, providing quantitative measurements for radiologists. KardiaAI, on the other hand, analyzes ambulatory ECG rhythms to detect various arrhythmias and rhythm abnormalities, typically integrating into mobile and web platforms for broader use.

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your primary need is automated, quantitative measurement of the cardiothoracic ratio from CT chest images. This tool is ideal for radiologists and cardiologists who require precise, AI-driven data to assist in the detection and monitoring of cardiomegaly within their existing CT imaging workflows or for research purposes. Its command-line interface and output formats (PDF/JSON) make it suitable for integration into automated processing pipelines.

View CT Cardiomegaly →

Choose KardiaAI if…

Choose KardiaAI if you need to integrate robust, FDA-cleared AI for real-time or ambulatory ECG rhythm analysis into mobile applications, wearable devices, or remote patient monitoring systems. This solution is best suited for developers and healthcare providers aiming to offer automated detection of various cardiac conditions like AFib, bradycardia, and tachycardia directly to patients or clinicians through integrated digital health platforms. Its API library facilitates seamless integration into existing software.

View KardiaAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CT Cardiomegaly KardiaAI
Pricing Fixed-fee Subscription-based for advanced features and services.
Deployment Docker Container (Ubuntu 20.04), command-line software Mobile app, cloud-based.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

KardiaAI

Tool A is a command-line software deployed via Docker, suggesting a more technical user base and requiring specific IT expertise for operation. In contrast, Tool B is an API library designed for integration into mobile apps and web platforms, which typically translates to a more user-friendly experience for clinicians and patients through intuitive interfaces.

Clinical Value

KardiaAI

Both tools offer significant clinical value and are FDA-cleared. Tool A provides quantitative cardiothoracic ratio measurements from CT images for cardiomegaly detection. Tool B, however, offers a broader range of AI-powered ECG analyses, detecting multiple critical cardiac conditions such as AFib, bradycardia, and tachycardia from ambulatory ECG rhythms, addressing a wider spectrum of common clinical needs.

Pricing & Value

KardiaAI

Tool A requires direct contact for pricing, lacking transparency. Tool B, on the other hand, provides clear, subscription-based pricing models (KardiaCare Monthly, Annual, and Plus) that are publicly available and offer different tiers of service, making its cost structure transparent and accessible to potential users.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. Tool A's Docker deployment and explicit HIPAA compliance and BAA offering cater to IT-managed environments. Tool B's API-first approach, coupled with its HIPAA compliance and BAA, makes it highly suitable for integration into existing enterprise healthcare systems and workflows, providing robust foundations for secure and scalable deployment.

Innovation

KardiaAI

Tool A innovates by automating precise cardiothoracic ratio measurements from CT images using machine learning and the MONAI framework. Tool B offers an innovative AI-powered API library for comprehensive ambulatory ECG analysis, enabling broad integration into various devices and platforms. KardiaAI's API-first approach for widespread integration of advanced ECG analysis might be considered more disruptive in terms of market reach and application.

Support & Docs

KardiaAI

Tool A, being a command-line tool, would likely have technical documentation, but it's not explicitly detailed, and support appears to be via direct vendor contact. Tool B, as an API library, inherently requires and typically provides extensive developer documentation, SDKs, and integration guides for successful implementation, which is crucial for its target audience of integrators and developers.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CT Cardiomegaly KardiaAI
Tool Name CT Cardiomegaly KardiaAI
Company Innolitics AliveCor
Primary Function/Modality Automated Cardiothoracic Ratio Measurement from CT Images AI software library for analyzing ambulatory ECG rhythms
Key Detections/Measurements Automatic cardiothoracic ratio measurement, segmentation of heart and thoracic cavity, calculates linear and area-based cardiothoracic ratios Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE)
Specialties Cardiology, Radiology Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring CT Cardiomegaly and KardiaAI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Innolitics' CT Cardiomegaly is designed to automatically measure the cardiothoracic ratio from CT chest images, assisting physicians in the detection of cardiomegaly with quantitative data. KardiaAI by AliveCor is an AI software library that analyzes ambulatory ECG rhythms to detect various cardiac conditions, including atrial fibrillation, bradycardia, and tachycardia.
CT Cardiomegaly requires CT chest images as its input for analysis. KardiaAI processes ambulatory ECG rhythms to identify cardiac conditions.
CT Cardiomegaly provides quantitative data, including linear and area-based cardiothoracic ratios, and outputs PDF and JSON reports. KardiaAI detects specific cardiac conditions such as atrial fibrillation, bradycardia, tachycardia, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, and Sinus Rhythm with Supraventricular Ectopy (SVE), and also offers ECG noise filtering.
CT Cardiomegaly is intended for use in Cardiology and Radiology specialties. KardiaAI supports Cardiology, Emergency Medicine, and Internal Medicine.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.